Connect with us

Corona

CORONAVIRUS RELIEF : Initiative phase of human trial of vaccine succeeds

Published

4 years ago

on

The eyes of the entire world are now once again on the University of Oxford regarding the Corona virus vaccine. In fact, after the initiative phase of the human trial of the vaccine being prepared by the university is being prepared, it is now being prepared to take it to another level.

PHOTO-GOOGLE

Researchers at the University of Oxford on Friday confirmed initial successes on the vaccine to protect against the corona virus, saying they are moving to another level of human testing. According to the researchers, they are going to the next level, starting to recruit more than 10,000 people for the second phase of testing.

The first phase of the trial on the vaccine began last month, with 1,000 healthy adults and volunteers under age 55 being trialled. Now over 10,200 people, including children over 70 years and 5 to 12 years old, will be enrolled for the study to see the impact on their immune system.

PHOTO – GOOGLE

A recent study found that the vaccine named ChAdOx1 nCoV-19 showed some promising results in small studies with monkeys. ‘The COVID-19 vaccine trial team is working hard to assess the safety and immunogenicity and vaccine efficacy of ChAdOx1 nCoV-19,’ said Sarah Gilbert, a professor of vaccineology at the university’s Jenner Institute.

PHOTO-GOOGLE

He said that we are already very interested in people over the age of 55 who were not eligible to participate in the first phase of research, and now we will be able to include older age groups to continue vaccination . We will cover many parts of the country as well as more study sites.

photo – google

ChAdOx1 nCoV-19 is composed of a virus (ChAdOx1), a weaker version of a common cold virus (adenovirus) that causes infection in chimpanzee, which has been genetically such that it is impossible to replicate in humans.

PHOTO – GOOGLE

With this new team of volunteers, researchers will assess immune responses to the vaccine in people of different ages to find out how well the immune system reacts in older people or children. The third phase of the study will study people over the age of 18 to see how it works on them.

HOCKEY INDIA : Safety of the athlete and staff member is paramount

 

Related Topics:
Continue Reading

Corona

Covid toll in Karnataka is a worrying sign for state government

Published

3 years ago

on

May 4, 2022

By

 

Even though Karnataka recorded the lowest number of Covid deaths in April since the virus struck first in 2020, the state is recording a rise in the positivity rate (1.50 per cent). Five people died from the Covid infections in April as per the statistics released by the state health department. In March, the positivity rate stood around 0.53 per cent. In the first week of April it came down to 0.38 per cent, second week registered 0.56 per cent, third week it rose to 0.79 per cent and by end of April the Covid positivity rate touched 1.19 per cent.

on an average 500 persons used to succumb everyday in the peak of Covid infection, as per the data. Health experts said that the mutated Coronavirus is losing its fierce characteristics as vaccination, better treatment facilities and awareness among the people have contributed to the lesser number of Covid deaths.

During the 4th and 6th of April two deaths were reported in Bengaluru, one in Gadag district on April 8, two deaths were reported from Belagavi and Vijayapura on April 30. The first Covid case was reported in the state in March 2020 and three Covid deaths were recorded in the month. In the following month 21 people became victims to the deadly virus, and May 2020 recorded 22 deaths. The death toll recorded everyday after May crossed three digits. However, the third wave, which started in January 2

Continue Reading

Trending